These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3894410)

  • 1. [Growth responses of Vibrio cholerae biotype eltor and Escherichia coli under the presence of bile acid and antibiotics].
    Aoki M
    Nihon Ika Daigaku Zasshi; 1985 Jun; 52(3):292-305. PubMed ID: 3894410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Properties of a transferable resistance factor in Vibrio cholerae biotype eltor].
    Rahal K; Gerbaud GR; Chabbert YA
    Ann Microbiol (Paris); 1973 Oct; 124(3):283-94. PubMed ID: 4599373
    [No Abstract]   [Full Text] [Related]  

  • 3. Vibrio cholerae tolC is required for bile resistance and colonization.
    Bina JE; Mekalanos JJ
    Infect Immun; 2001 Jul; 69(7):4681-5. PubMed ID: 11402016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Responses of E1 Tor cholera Vibrio to antibiotics in relation to intestinal flora: antibiotic sensitivity and behaviors in mixed culture with resistant E. coli].
    Kino I
    Nihon Ika Daigaku Zasshi; 1983 Oct; 50(5):702-15. PubMed ID: 6363444
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of bile on the cell surface permeability barrier and efflux system of Vibrio cholerae.
    Chatterjee A; Chaudhuri S; Saha G; Gupta S; Chowdhury R
    J Bacteriol; 2004 Oct; 186(20):6809-14. PubMed ID: 15466033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of R plasmid from Staphylococcus aureus to Escherichia coli & Vibrio cholerae.
    Chakrabarty AN; Sen M; Balganesh TS; Dastidar SG
    Indian J Exp Biol; 1981 Jun; 19(6):511-5. PubMed ID: 7024113
    [No Abstract]   [Full Text] [Related]  

  • 7. [Growth responses of Salmonella typhi in the presence of antibiotics, bile acid and Escherichia coli].
    Kato S
    Nihon Ika Daigaku Zasshi; 1986 Aug; 53(4):375-87. PubMed ID: 3531223
    [No Abstract]   [Full Text] [Related]  

  • 8. The stability of R plasmids in Vibrio cholerae.
    Arai T; Yao-Sugawara K; Aoki T
    Keio J Med; 1980 Jun; 29(3):125-32. PubMed ID: 7024610
    [No Abstract]   [Full Text] [Related]  

  • 9. Bile acids induce cholera toxin expression in Vibrio cholerae in a ToxT-independent manner.
    Hung DT; Mekalanos JJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3028-33. PubMed ID: 15699331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vibrio cholerae leuO Transcription Is Positively Regulated by ToxR and Contributes to Bile Resistance.
    Ante VM; Bina XR; Howard MF; Sayeed S; Taylor DL; Bina JE
    J Bacteriol; 2015 Nov; 197(22):3499-510. PubMed ID: 26303831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotype traits and antibiotic susceptibility of Vibrio cholerae serogroup O1 before, during and after the emergence of the O139 serogroup.
    Mukhopadhyay AK; Garg S; Nair GB; Kar S; Ghosh RK; Pajni S; Ghosh A; Shimada T; Takeda T; Takeda Y
    Epidemiol Infect; 1995 Dec; 115(3):427-34. PubMed ID: 8557074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of medium-chain monoglycerides on intestinal colonisation by Vibrio cholerae or enterotoxigenic Escherichia coli.
    Petschow BW; Batema RP; Talbott RD; Ford LL
    J Med Microbiol; 1998 May; 47(5):383-9. PubMed ID: 9879938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and Efficient Elimination of
    Oh YT; Kim HY; Kim EJ; Go J; Hwang W; Kim HR; Kim DW; Yoon SS
    Front Cell Infect Microbiol; 2016; 6():156. PubMed ID: 27900286
    [No Abstract]   [Full Text] [Related]  

  • 14. The in vitro sensitivity of Bibrio Cholerae strains to sulfamethopyrazine and aminosidine and data on the transfer of drug resistance from E. coli to some cholera agent strains.
    Ruiz Merino J; Buogo A
    Farmaco Prat; 1973 Apr; 28(4):210-7. PubMed ID: 4572388
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of conjugated and unconjugated bile acids on the activity of the Vibrio cholerae porin OmpT.
    Pagel M; Delcour AH
    Mol Membr Biol; 2011 Jan; 28(1):69-78. PubMed ID: 21067451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the indigenous Vibrio cholerae: classical versus ElTor biotypes.
    Aggarwal P; Raichowdhuri AN
    J Commun Dis; 1982 Dec; 14(4):247-50. PubMed ID: 7184950
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibacterial susceptibility/resistance of Vibrio cholerae eltor clinical strains isolated in the Caucasus during the seventh cholera pandemic].
    Savel'ev VN; Babenyshev BV; Savel'eva IV; Vasil'eva OV; Guseva LV; Grizhebovskiĭ GM; Kurbanov ShKh; Asvarov BM; Batyrova BA; Doroshenko IG; Antonenko AD
    Antibiot Khimioter; 2010; 55(5-6):8-13. PubMed ID: 21033468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial--resistance of vibrio cholerae biotype eltor.
    Kongsamran S; Dhiraputra C
    J Med Assoc Thai; 1975 Jun; 58(6):339-40. PubMed ID: 1141793
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of the Vibrio cholerae vexAB and vexCD efflux systems.
    Bina JE; Provenzano D; Wang C; Bina XR; Mekalanos JJ
    Arch Microbiol; 2006 Sep; 186(3):171-81. PubMed ID: 16804679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of R plasmids belonging to different incompatibility groups in Vibrio cholerae "Eltor".
    Rahal K; Gerbaud G; Bouanchaud DH
    Ann Microbiol (Paris); 1978; 129(4):409-14. PubMed ID: 697261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.